A carregar...
The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma
The unsatisfactory outcomes for osteosarcoma necessitate novel therapeutic strategies. This study evaluated the effect of the telomerase inhibitor imetelstat in pre-clinical models of human osteosarcoma. Because the chaperone molecule HSP90 facilitates the assembly of telomerase protein, the ability...
Na minha lista:
Publicado no: | Cancer Biol Ther |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622625/ https://ncbi.nlm.nih.gov/pubmed/25920748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1040964 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|